Two Sigma Advisers’s Sage Therapeutics SAGE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.81M Sell
198,799
-126,200
-39% -$1.15M ﹤0.01% 1171
2025
Q1
$2.58M Buy
324,999
+207,200
+176% +$1.65M 0.01% 1053
2024
Q4
$640K Sell
117,799
-2,600
-2% -$14.1K ﹤0.01% 1676
2024
Q3
$869K Sell
120,399
-30,200
-20% -$218K ﹤0.01% 1479
2024
Q2
$1.64M Buy
150,599
+124,099
+468% +$1.35M ﹤0.01% 1300
2024
Q1
$497K Buy
26,500
+1,100
+4% +$20.6K ﹤0.01% 1871
2023
Q4
$550K Buy
+25,400
New +$550K ﹤0.01% 1883
2023
Q3
Sell
-44,098
Closed -$2.07M 2554
2023
Q2
$2.07M Sell
44,098
-87,700
-67% -$4.12M 0.01% 1180
2023
Q1
$5.53M Sell
131,798
-24,500
-16% -$1.03M 0.01% 768
2022
Q4
$5.96M Buy
156,298
+21,000
+16% +$801K 0.02% 711
2022
Q3
$5.3M Buy
135,298
+67,700
+100% +$2.65M 0.02% 709
2022
Q2
$2.18M Buy
67,598
+26,598
+65% +$859K 0.01% 1169
2022
Q1
$1.36M Sell
41,000
-4,200
-9% -$139K ﹤0.01% 1470
2021
Q4
$1.92M Sell
45,200
-3,300
-7% -$140K ﹤0.01% 1221
2021
Q3
$2.15M Sell
48,500
-179,299
-79% -$7.94M 0.01% 1209
2021
Q2
$12.9M Sell
227,799
-134,900
-37% -$7.66M 0.03% 470
2021
Q1
$27.1M Sell
362,699
-59,100
-14% -$4.42M 0.07% 283
2020
Q4
$36.5M Sell
421,799
-109,600
-21% -$9.48M 0.1% 219
2020
Q3
$32.5M Sell
531,399
-200,600
-27% -$12.3M 0.09% 215
2020
Q2
$30.4M Buy
731,999
+281,800
+63% +$11.7M 0.09% 236
2020
Q1
$12.9M Buy
+450,199
New +$12.9M 0.05% 407
2019
Q4
Sell
-6,000
Closed -$842K 2458
2019
Q3
$842K Buy
+6,000
New +$842K ﹤0.01% 1507
2018
Q3
Sell
-12,600
Closed -$1.97M 2363
2018
Q2
$1.97M Sell
12,600
-21,200
-63% -$3.32M 0.01% 1298
2018
Q1
$5.44M Buy
33,800
+20,900
+162% +$3.37M 0.01% 817
2017
Q4
$2.13M Buy
+12,900
New +$2.13M 0.01% 1215
2017
Q3
Sell
-2,800
Closed -$223K 2335
2017
Q2
$223K Sell
2,800
-1,300
-32% -$104K ﹤0.01% 2087
2017
Q1
$291K Buy
+4,100
New +$291K ﹤0.01% 2096